Full Text
PCN240 - ALL-COMERS VS. BIOMARKER BASED PATIENT SELECTION FOR BIOTHERAPIES IN ONCOLOGY- IMPACT ON DRUG DEVELOPMENT AND MARKET ACCESS

Abstract

Authors

M. Massetti H. Leleu A. Vimont C. Antier M. Blachier

Back to Volume 21, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×